Arrayit Corp., a proprietary life science company that has been the universal standard for printing and spotting microarrays since 1997, recently announced that the company’s worldwide product sales increased approximately 50 percent in the first half of 2009 to more than $3.1 million. Currently, more than 10,000 customers and 5,000 worldwide laboratories are utilizing the Arrayit advantage.

Arrayit has built a sophisticated network of 38 international life science and diagnostics distributors in 36 countries. Arrayit leads the genetic, research, pharmaceutical and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.

Arrayit products, which are some of the most sophisticated tools for research into diagnostics, allow healthcare professionals, pharmaceutical companies, government laboratories, life science companies, academic institutions, biotechnology companies and hospitals to quickly and accurately identify specific diseases, pathogens and viruses in humans, animals or plants.

Let us hear your thoughts below:

Last 5 posts by QualityStocks

• Omnicity Corp. (OMCY.OB) Announces Addition of New Board Member - November 20th, 2009
• Muscle Flex, Inc. (MFLI.PK) Announces Release Time for the BUDDY Tablet Caddy Two-Minute Commercial and Landing Page - November 20th, 2009
• Artfest International, Inc. (ARTS.OB) Announces Revenue Profit Jumps - November 20th, 2009
• Omnicity Corp.’s (OMCY.OB) Recently-Issued Corporate Update - November 20th, 2009
• Soligenix Inc. (SNGX.OB) Taking Steps to Meet Challenges of Vaccine Technology and Biological Warfare - November 20th, 2009